Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
- PMID: 24185513
- DOI: 10.1038/ng.2806
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Abstract
The impact of different carcinogenic exposures on the specific patterns of somatic mutation in human tumors remains unclear. To address this issue, we profiled 209 cholangiocarcinomas (CCAs) from Asia and Europe, including 108 cases caused by infection with the liver fluke Opisthorchis viverrini and 101 cases caused by non-O. viverrini-related etiologies. Whole-exome sequencing (n = 15) and prevalence screening (n = 194) identified recurrent somatic mutations in BAP1 and ARID1A, neither of which, to our knowledge, has previously been reported to be mutated in CCA. Comparisons between intrahepatic O. viverrini-related and non-O. viverrini-related CCAs demonstrated statistically significant differences in mutation patterns: BAP1, IDH1 and IDH2 were more frequently mutated in non-O. viverrini CCAs, whereas TP53 mutations showed the reciprocal pattern. Functional studies demonstrated tumor suppressive functions for BAP1 and ARID1A, establishing the role of chromatin modulators in CCA pathogenesis. These findings indicate that different causative etiologies may induce distinct somatic alterations, even within the same tumor type.
Similar articles
-
Exome sequencing of liver fluke-associated cholangiocarcinoma.Nat Genet. 2012 May 6;44(6):690-3. doi: 10.1038/ng.2273. Nat Genet. 2012. PMID: 22561520
-
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.Nat Genet. 2013 Dec;45(12):1470-1473. doi: 10.1038/ng.2813. Epub 2013 Nov 3. Nat Genet. 2013. PMID: 24185509 Free PMC article.
-
Genomic and transcriptional alterations of cholangiocarcinoma.J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):380-7. doi: 10.1002/jhbp.67. Epub 2014 Feb 13. J Hepatobiliary Pancreat Sci. 2014. PMID: 24532422 Review.
-
Genetics of Opisthorchis viverrini-related cholangiocarcinoma.Curr Opin Gastroenterol. 2015 May;31(3):258-63. doi: 10.1097/MOG.0000000000000162. Curr Opin Gastroenterol. 2015. PMID: 25693006 Review.
-
Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans.Hepatology. 2011 Oct;54(4):1388-97. doi: 10.1002/hep.24518. Epub 2011 Sep 6. Hepatology. 2011. PMID: 21725997 Free PMC article.
Cited by
-
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.Clin Genet. 2016 Mar;89(3):285-94. doi: 10.1111/cge.12630. Epub 2015 Jul 14. Clin Genet. 2016. PMID: 26096145 Free PMC article. Review.
-
Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.Curr Treat Options Oncol. 2016 Nov;17(11):58. doi: 10.1007/s11864-016-0432-2. Curr Treat Options Oncol. 2016. PMID: 27658789 Review.
-
Neglected Agent Eminent Disease: Linking Human Helminthic Infection, Inflammation, and Malignancy.Front Cell Infect Microbiol. 2019 Dec 6;9:402. doi: 10.3389/fcimb.2019.00402. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31867284 Free PMC article. Review.
-
Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer.Sci Rep. 2022 Feb 4;12(1):1931. doi: 10.1038/s41598-022-05914-4. Sci Rep. 2022. PMID: 35121803 Free PMC article.
-
BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.Cell Death Dis. 2018 Oct 10;9(10):1036. doi: 10.1038/s41419-018-1087-7. Cell Death Dis. 2018. PMID: 30305612 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous